Solution for oral use Agvantar is appointed at the following indications:

• Primary (congenital) insufficiency of a carnitine.
• Secondary insufficiency of a carnitine.

Structure

Active ingredient: levocarnitine;

1 ml to a left carnitine of 200 mg;

Excipients: methylparaben (E 218), propylparaben (E 216), sucrose, sorbite (E 420), banana fragrance, water purified.

Contraindication

Hypersensitivity to medicament components.

Dose and duration of treatment the doctor establishes

individually depending on age and a nosological form of a disease. Agvantar to accept inside in 30 minutes prior to food. To use the dosing syringe or a measured glass to dosing.

Pregnant

medicament Use to pregnant women is only possible

Feature of use when the expected advantage for mother exceeds possible potential risk for a fruit.

Children

Agvantar can apply

children (full-term and premature newborns) from the first day of life.

Drivers

does not influence.

Overdose

Data on overdose of drug.

Side effects

from digestive tract: dispepsichesky disorders, pains in epigastric area, nausea, vomiting, diarrhea.

from the immune system, at individual intolerance can sometimes cause allergic reactions (perhaps, the slowed-down type).

Others: body smell.

Simultaneous use of glucocorticoids leads

to accumulation of a left carnitine in body tissues (except a liver). Other anabolic means enhance effect of drug.

Storage conditions

to Store

at a temperature not above 25 °C.

to Store

out of children's reach.

Expiration date - 2 years.